Week ending 5th November
We started off the week talking about Brexit, specifically about What future for UK copyright after Brexit? Report on IPKat-BLACA panel discussion. Kat Eleonora moderated the panel and reported on it for us.
Talking about abusive forum shopping by non-practicing entities, Kat friends Bryan Kohm, David Tellekson, Melanie Mayer and Reilly Stoler guided us on how US patent litigation on the move again following In re Cray.
Does the doctrine of equivalents apply to novelty? Guest Kat Eibhlin answers the question by analyzing the recent decision Generics (U.K) v Yeda, a practical application of the Supreme Court’s Actavis v Eli Lilly.
Internet and Digital Media Law conference returns to London! The conference will be held on 5 December and a discount for participation is kindly offered for IPKat readers…register away! Also on 5 December: Christmas UNION-IP event: "IP - Past, Present and Future", with notable speaker Mr Justice Colin Birss. Don’t miss out on it!
Registering EUTMs with pictorial characters can be challenging, as Kat friend Matej Michalec knows all too well. In The Relevant Public and Likelihood of Confusion in Respect of Chinese Character Trademarks he discusses this topic.
The AmeriKat continued with her report from AIPPI Congress with incredible instalment numbing number 14: GUI Goo for Chewy Chewing.
What happens to user rights when IP serves the basis for a product, How far to take user rights into consideration? Repair? Kat Neil reports.
Bringing a counterclaim for patent revocation: not so fast in Singapore: Kat friend Sheena Jacob talks about how this may not be possible any longer.
SPC consultation - call for input: the European Commission is seeking for contributions!
When Twitter, football and copyright law meet: Linking in the US: is an embedded tweet an infringement of the public display right? Kat Eleonora discusses the improbable encounter.
Are you interested in being an InternKat or a Guest Kat? Then respond to our Katcall: Openings for GuestKats and InternKats!
Important news on the second medical use claims world as Dutch Supreme Court in Merck v Teva holds that second medical use claims can be directly and indirectly infringed, no matter the type. As the decision was mint fresh and no English was available, Kat friend Tobias Cohen Jehoram provided a translation and a summary in English for us.
Unpredictable times come with unpredictable patent decisions. Kat Annsley talks about Court of Appeal’s decision Actavis v ICOs in The rise of "obvious to try" is over as Court of Appeal finds CIALIS dosage regimen patent obvious.
Weekly roundups: Wednesday Whimsies
![]() |
Two Never Too Late are Better than One! |
Rosie informs us on the recent High Court appeal of Abanka DD v Abanca Corporacion Bancaria SA [2017], which concerns the revocation of two international trade marks for ABANKA and the related opposition to the application to register ABANCA. No prizes for guessing which party was attacking which mark.
IP Federation declares no role for IP disputes in proposed Hague Convention, while INTA takes a different approach
Book review: Grounds of the Immaterial - A Conflict-based Approach to Intellectual Property Rights
Teva v Gilead: Swiss court bashes ECJ on SPC "mess"
Book Review: Form in Intellectual Property Law
T 1201/14: EPC's substantive requirements for valid transfer of priority right surprisingly substantial
In T 1201/14 of 9 February 2017 (grounds published on 5 September 2017), the Board of Appeal 3.5.05 took the opportunity to clarify some aspects on the ever- challenging assignment of the priority right for a European patent application.
Qatar diplomatic crisis: “beIN Sports” and potential violations of the TRIPS Agreement – Part 2
Katfriend Riyadh Al-Balushi continues with part 2 of his post, whichtackles the TRIPS-relevant aspects of the crisis, including with regard to TV network beIN Sports.
TV formats potentially eligible for copyright protection as dramatic works under UK law
No comments:
Post a Comment